Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Fuhr

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|January 12, 1999
Drug metabolism biosensors: electrochemical reactivities of cytochrome P450cam immobilised in synthetic vesicular systemsE I Iwuoha, S Joseph, Z Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2009
Development of a new G-CSF product based on biosimilarity assessmentP Gascon, U Fuhr, F Sörgel, et al.
Toxicology|October 5, 1993
Biotransformation of methylxanthines in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms. Allocation of metabolic pathways to isoforms and inhibitory effects of quinolonesU Fuhr, J Doehmer, N Battula, et al.
Clinical Pharmacology and Therapeutics|March 30, 1999
Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2M Kinzig-Schippers, U Fuhr, M Zaigler, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 5, 2002
Screening for inhibitory effects of antineoplastic agents on CYP3A4 in human liver microsomesM Baumhäkel, D Kasel, R A Rao-Schymanski, et al.
Clinical Pharmacology and Therapeutics|October 1, 2010
Assessment of activity levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 genes by population pharmacokinetics of dextromethorphanK Abduljalil, D Frank, A Gaedigk, et al.
Pharmacology & Toxicology|July 15, 2000
Inhibitory effects of silibinin on cytochrome P-450 enzymes in human liver microsomesS Beckmann-Knopp, S Rietbrock, R Weyhenmeyer, et al.
Clinical Pharmacokinetics|January 1, 1992
Effects of temafloxacin and ciprofloxacin on the pharmacokinetics of caffeineG Mahr, F Sörgel, G R Granneman, et al.
European Journal of Endocrinology|August 9, 2018
Enzyme autoinduction by mitotane supported by population pharmacokinetic modelling in a large cohort of adrenocortical carcinoma patientsU Arshad, M Taubert, M Kurlbaum, et al.
Arzneimittel-Forschung|October 1, 1989
Study of potential kinetic interactions of picumast dihydrochloride and theophylline in vitro and after oral administration in manA M Wittenbrink-Dix, G Neugebauer, U Fuhr, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Journal of Pharmaceutical and Biomedical Analysis|January 12, 1999
Drug metabolism biosensors: electrochemical reactivities of cytochrome P450cam immobilised in synthetic vesicular systemsE I Iwuoha, S Joseph, Z Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2009
Development of a new G-CSF product based on biosimilarity assessmentP Gascon, U Fuhr, F Sörgel, et al.
Toxicology|October 5, 1993
Biotransformation of methylxanthines in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms. Allocation of metabolic pathways to isoforms and inhibitory effects of quinolonesU Fuhr, J Doehmer, N Battula, et al.
Clinical Pharmacology and Therapeutics|March 30, 1999
Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2M Kinzig-Schippers, U Fuhr, M Zaigler, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 5, 2002
Screening for inhibitory effects of antineoplastic agents on CYP3A4 in human liver microsomesM Baumhäkel, D Kasel, R A Rao-Schymanski, et al.
Clinical Pharmacology and Therapeutics|October 1, 2010
Assessment of activity levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 genes by population pharmacokinetics of dextromethorphanK Abduljalil, D Frank, A Gaedigk, et al.
Pharmacology & Toxicology|July 15, 2000
Inhibitory effects of silibinin on cytochrome P-450 enzymes in human liver microsomesS Beckmann-Knopp, S Rietbrock, R Weyhenmeyer, et al.
Clinical Pharmacokinetics|January 1, 1992
Effects of temafloxacin and ciprofloxacin on the pharmacokinetics of caffeineG Mahr, F Sörgel, G R Granneman, et al.
European Journal of Endocrinology|August 9, 2018
Enzyme autoinduction by mitotane supported by population pharmacokinetic modelling in a large cohort of adrenocortical carcinoma patientsU Arshad, M Taubert, M Kurlbaum, et al.
Arzneimittel-Forschung|October 1, 1989
Study of potential kinetic interactions of picumast dihydrochloride and theophylline in vitro and after oral administration in manA M Wittenbrink-Dix, G Neugebauer, U Fuhr, et al.
Pageof 9